LeMaitre Vascular Future Growth
Future criteria checks 1/6
LeMaitre Vascular is forecast to grow earnings and revenue by 12.7% and 7.6% per annum respectively. EPS is expected to grow by 11.6% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
12.7%
Earnings growth rate
11.6%
EPS growth rate
Medical Equipment earnings growth | 17.5% |
Revenue growth rate | 7.6% |
Future return on equity | 13.3% |
Analyst coverage | Good |
Last updated | 20 Aug 2024 |
Recent future growth updates
Recent updates
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 256 | 54 | 60 | 58 | 6 |
12/31/2025 | 237 | 47 | 52 | 54 | 9 |
12/31/2024 | 218 | 42 | 37 | 46 | 9 |
6/30/2024 | 206 | 38 | 32 | 37 | N/A |
3/31/2024 | 200 | 34 | 33 | 40 | N/A |
12/31/2023 | 193 | 30 | 29 | 37 | N/A |
9/30/2023 | 186 | 27 | 23 | 30 | N/A |
6/30/2023 | 177 | 25 | 19 | 26 | N/A |
3/31/2023 | 169 | 21 | 18 | 23 | N/A |
12/31/2022 | 162 | 21 | 22 | 25 | N/A |
9/30/2022 | 160 | 21 | 24 | 26 | N/A |
6/30/2022 | 160 | 22 | 29 | 33 | N/A |
3/31/2022 | 158 | 27 | 29 | 34 | N/A |
12/31/2021 | 154 | 27 | 30 | 35 | N/A |
9/30/2021 | 152 | 28 | 39 | 44 | N/A |
6/30/2021 | 151 | 29 | 40 | 44 | N/A |
3/31/2021 | 135 | 24 | 37 | 40 | N/A |
12/31/2020 | 129 | 21 | 32 | 35 | N/A |
9/30/2020 | 122 | 19 | 23 | 26 | N/A |
6/30/2020 | 115 | 16 | 13 | 17 | N/A |
3/31/2020 | 119 | 18 | 12 | 16 | N/A |
12/31/2019 | 117 | 18 | 10 | 14 | N/A |
9/30/2019 | 115 | 19 | 12 | 15 | N/A |
6/30/2019 | 111 | 18 | 12 | 15 | N/A |
3/31/2019 | 108 | 23 | 12 | 16 | N/A |
12/31/2018 | 106 | 23 | 16 | 20 | N/A |
9/30/2018 | 103 | 21 | 16 | 20 | N/A |
6/30/2018 | 104 | 22 | 18 | 24 | N/A |
3/31/2018 | 103 | 18 | N/A | 24 | N/A |
12/31/2017 | 101 | 17 | N/A | 23 | N/A |
9/30/2017 | 98 | 15 | N/A | 20 | N/A |
6/30/2017 | 96 | 14 | N/A | 18 | N/A |
3/31/2017 | 93 | 12 | N/A | 18 | N/A |
12/31/2016 | 89 | 11 | N/A | 17 | N/A |
9/30/2016 | 86 | 11 | N/A | 17 | N/A |
6/30/2016 | 82 | 9 | N/A | 14 | N/A |
3/31/2016 | 79 | 9 | N/A | 13 | N/A |
12/31/2015 | 78 | 8 | N/A | 11 | N/A |
9/30/2015 | 76 | 7 | N/A | 10 | N/A |
6/30/2015 | 74 | 6 | N/A | 9 | N/A |
3/31/2015 | 73 | 5 | N/A | 7 | N/A |
12/31/2014 | 70 | 4 | N/A | 6 | N/A |
9/30/2014 | 70 | 3 | N/A | 4 | N/A |
6/30/2014 | 67 | 3 | N/A | 4 | N/A |
3/31/2014 | 65 | 2 | N/A | 4 | N/A |
12/31/2013 | 64 | 3 | N/A | 5 | N/A |
9/30/2013 | 61 | 3 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LMAT's forecast earnings growth (12.7% per year) is above the savings rate (2.5%).
Earnings vs Market: LMAT's earnings (12.7% per year) are forecast to grow slower than the US market (15.2% per year).
High Growth Earnings: LMAT's earnings are forecast to grow, but not significantly.
Revenue vs Market: LMAT's revenue (7.6% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: LMAT's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LMAT's Return on Equity is forecast to be low in 3 years time (13.3%).